Where are you?

To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.


Media & Investors

Transparency is important to us. Find important information about Kuros Biosciences here – from our corporate documents to our current share price.

Press releases

Here are our latest press releases.
For archived news items, please go to our Resources center. To subscribe to receive our press releases, please click here.

12 Oct 2023

Adhoc Press Release

Kuros reports a 150% increase in direct MagnetOs sales in the first nine months of 2023 and announces changes within the Executive Management

09 Aug 2023

Adhoc Press Release

Kuros Biosciences Reports Results for First Half 2023

13 Jul 2023

Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial

08 May 2023

Adhoc Press Release

Annual General Meeting of Kuros Biosciences approves all resolutions

27 Apr 2023

Adhoc Press Release

Kuros reports 168% increase in direct MagnetOs sales in the first quarter of 2023

15 Mar 2023

Adhoc Press Release

Kuros Biosciences reports results for the full year 2022

Investor calendar

Date Event
Mar 13, 2024

Publish Financial Report 2023

Apr 24, 2024

Trading Update Q1 2024

Reports, Corporate Governance & Meetings

Kuros Biosciences is fully committed to good corporate governance and adherence to high ethical standards. Our principles and rules on corporate governance and ethical conduct are articulated in the Articles of Association, the Internal Regulations, the charters of the committees of our board of directors, and our code of conduct.

Reports & Presentations

Corporate Governance

Shareholder Meetings

Regulatory filings

Information on disclosures under the Swiss Stock Exchange Act can be found on the website of the SIX Swiss Exchange website.

Management Transactions

Outstanding Options

Significant Shareholder Transactions



For more information regarding analyst reports, please contact:

Laura Pfeifer-Rossi
Octavian AG
Tel: +41 44 520 1588

Want to receive our press releases?